Autopsy report · NCT01507532

Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients

“did not enroll a patient”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Midwestern University

Sponsor type

University, hospital or other

Conditions

Renal Failure

Interventions

pharmacokinetic monitoring

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Efficacy of rTMS (Repetitive Transcranial Magnetic Stimulation) on Patients With Somatoform Pain Disorder
  “patient did not enroll” (93% match in meaning)
• The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
  “Unable to enroll patients” (81% match in meaning)
• Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)
  “Did not enroll” (80% match in meaning)
• A Randomized, Prospective Clinical Trial of Immediate Flap Closure Versus Wound Care for Management of Late-stage Pressure Ulcers
  “We have not been able to enroll patients.” (79% match in meaning)
• Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
  “Unable to enroll appropriate patients” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.